NCT01921530

Brief Summary

Degenerative spondylolisthesis describes the slip of one spinal segment relative to the adjacent segment. It is usually associated with spinal stenosis (which limits one's ability to walk and stand) and is the most common indication for surgery in adults over age 65 years. A variety of surgical techniques are available; the most common are the Posterolateral Instrumented Fusion (PLF), and Interbody Fusion (IF) including Posterolateral Interbody Fusion (PLIF), and Transforaminal Interbody fusion (TLIF). IF uses a cage that is placed within the cleaned out disc space between the vertebral bodies being fused. Although this approach achieves a good fusion rate and deformity correction it is associated with a higher surgical cost and potential intra-operative complication rate. What is more, no consensus exists as to whether IF provides better patient rated functional outcome and quality of life. If the advantages of IF do not translate into superior patient rated outcomes, then the risk-benefit ratio would be tipped in favor of PLF. The purpose of this study is to determine if IF is equivalent to PLF for the treatment of degenerative spondylolisthesis. The investigators will conduct a prospective randomized control trial comparing these two procedures. Our primary outcome measure will be the Oswestry Disability Index, which evaluates spinal pain and function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
178

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 13, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 20, 2018

Status Verified

August 1, 2018

Enrollment Period

5 years

First QC Date

August 9, 2013

Last Update Submit

August 17, 2018

Conditions

Keywords

Posterolateral FusionInterbody FusionLumbarSpinal StenosisDegenerative Spondylolisthesis

Outcome Measures

Primary Outcomes (1)

  • Oswestry Disability Index

    The Oswestry Disability Index is an effective method of measuring disability in patients with back and leg pain and is well suited to patients who have had persistent severe disability. It is a commonly utilized, validated, and highly reproducible. The questionnaire can be completed in less than 5 minutes and a large amount of normative data exists.

    1 year post surgery

Secondary Outcomes (1)

  • Oswestry Disability Index

    Enrollment, and at 6 weeks, 3 months, 6 months, 2 years, 5 years and post surgery

Other Outcomes (7)

  • Visual Analogue Scale for back pain intensity (0-10: 0= no pain, 10=worst pain)

    Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery

  • Visual Analogue Scale for leg pain intensity (0-10: 0= no pain, 10=worst pain)

    Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery

  • SF-12 (General Health outcome measure)

    Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery

  • +4 more other outcomes

Study Arms (2)

Interbody Fusion

ACTIVE COMPARATOR
Procedure: Interbody Fusion

Posterolateral Fusion

ACTIVE COMPARATOR
Procedure: Posterolateral Fusion

Interventions

The interbody fusion (IF) procedure requires exposure and removal of the disc, curetting the end plates, inserting a cage filled with bone graft, as well as stabilization with rods and screws.

Also known as: Posterolateral Interbody Fusion (PLIF), Transforaminal Interbody fusion (TLIF)
Interbody Fusion

In posterolateral fusion stabilization is achieved using pedicle screws joined by rods. The graft used to facilitate fusion is placed between decorticated transverse processes and can be an autograft of iliac bone or local bone, allograft, or a synthetic expander.

Posterolateral Fusion

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 50 years or older
  • Grade I or II (less than 50% slip of the cephalad vertebra compared to the caudal vertebra) degenerative spondylolisthesis at one or two contiguous levels between L1 and L5.
  • Lumbar spinal stenosis at the same levels of the degenerative spondylolisthesis producing radiculopathy or neurogenic claudication unresponsive to a minimum of 3 months of non surgical treatment
  • Patients who are medically suitable for surgical management
  • Patients who have consented for surgical treatment
  • Patients able to provide informed consent for the study and complete the questionnaires

You may not qualify if:

  • Lytic spondylolisthesis
  • Non degenerative stenosis (example: tumor, trauma, epidural lipomatosis)
  • Severe vertical foraminal stenosis necessitating interbody insertion to re-establish foraminal height
  • Segmental kyphosis at the level of the spondylolisthesis
  • Segmental scoliosis \>10 degrees at the level of the spondylolisthesis
  • Rheumatoid arthritis
  • Active infection
  • On long term disability or workers compensation claim
  • Drug or alcohol misuse
  • Lack of permanent home residence
  • Previous surgery at the proposed surgical level
  • Previous fusion in the lumbar spine
  • Contraindication to surgery: medical co morbidities
  • Unable to complete questionnaire (e.g. Dementia)
  • Unable to give voluntary consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6G 5L7, Canada

RECRUITING

MeSH Terms

Conditions

Spinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Christopher S Bailey, MD

    The London Spine Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christopher S Bailey, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2013

First Posted

August 13, 2013

Study Start

December 1, 2013

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

August 20, 2018

Record last verified: 2018-08

Locations